The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
DNA targeting specificity of RNA-guided Cas9 nucleases
Open accessAbstract
The Streptococcus pyogenes Cas9 (SpCas9) nuclease can be efficiently targeted to genomic loci by means of single-guide RNAs (sgRNAs) to enable genome editing. Here, we characterize SpCas9 targeting specificity in human cells to inform the selection of target sites and avoid off-target effects. Our study evaluates >700 guide RNA variants and SpCas9-induced indel mutation levels at >100 predicted genomic off-target loci in 293T and 293FT cells. We find that SpCas9 tolerates mismatches between guide RNA and target DNA at different positions in a sequence-dependent manner, sensitive to the number, position and distribution of mismatches. We also show that SpCas9-mediated cleavage is unaffected by DNA methylation and that the dosage of SpCas9 and sgRNA can be titrated to minimize off-target modification. To facilitate mammalian genome engineering applications, we provide a web-based software tool to guide the selection and validation of target sequences as well as off-target analyses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, off-target cleavages of the Cas9 nucleases that cause oncogenic mutations in the genome have been reported extensively [123,124].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The off-target sites are often sgRNA-dependent, since Cas9 is known to tolerate up to 3 mismatches between sgRNA and genomic DNA (Fu et al., 2013; Hsu et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although CRISPR/Cas systems exhibit tremendous potential in translational medicine, off-target effects remain a major challenge (Fu et al., 2013; Hsu et al., 2013; Pacesa et al., 2022).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and it maintains cleaving activity even with 3-5 mismatches at the PAM-distal end of the gRNA molecule [59,81,102].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [102]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The algorithm of MIT weights the position effect of the mismatches in the sgRNA to generate a score to evaluate off-target effects (Hsu et al., 2013; Haeussler et al., 2016).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“The PAM sequence adjacent to the target sequence greatly affects the editing efficiency and editing range of Cas9.”
From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Cas9 is guided by a 20 nt fraction of the gRNA”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [102]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [63]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“When two sgRNAs are designed to simultaneously cut the two opposite strands of DNA within a small distance, DSBs can be created with markedly lower off-target effects (Hsu et al., 2013; Frock et al., 2015).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Hsu et al., 2013
Experimental — accuracy not yet measuredIn the citing paper
“By bioinformatic screening and efficiency/off-target prediction (14, 15), we identified four gRNA targets (protospacers; LTRs A-D) that avoid conserved transcription factor binding sites, minimizing the likelihood of altering host gene expression”
From RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection (2014) · cites this paper as [14]
In the citing paper
“as mentioned in several recent publications, Cas9 tolerates mismatches between the guide RNA and target DNA in a sequence-dependent manner and potentially tolerates up to five target mismatches in human cells [12], [24], [25], [26], [27], thereby promoting undesired off-target mutations.”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“Because the sequence specificity of Streptococcus pyogenes Cas9 tolerates 4 mismatches between the gRNA and complementary sequence”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“non-specific cleavage may occur in the cellular genome [12], [24], [25], [26], [27].”
From High-efficiency targeted editing of large viral genomes by RNA-guided nucleases (2014) · cites this paper as [25]
In the citing paper
“However, it has been recently shown that CRISPR/Cas9 system can be highly active even when mismatches occur between gRNA and their DNA targets”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“multiple mismatches between the guide RNA and its complementary target DNA sequence can be tolerated depending on the quantity, position, and base identity of mismatches [87,90,91,93], all of which contribute to potential off-target activity.”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“and off-target mutations occur at endogenous loci in human cells with high frequency [90,91,92].”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
In the citing paper
“Collectively, these studies indicate that although each base within the 20 nt guide sequence contributes to overall specificity”
From Newer Gene Editing Technologies toward HIV Gene Therapy (2013) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
Self-citationEfficient genome editing in zebrafish using a CRISPR-Cas system
Hwang, W. Y., Fu, Y., Reyon, D., Maeder, M. L., Tsai, S. Q., Sander, J. D., Peterson, R. T., Yeh, J.-R. J., & Joung, J. K. (2013) · Nature Biotechnology · doi:10.1038/nbt.2501 · Cited by 2,937
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Self-citationA TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,041
Genome editing in cardiovascular diseases
Strong, A., & Musunuru, K. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.139 · Cited by 91
Sarin, S., Zuniga-Sanchez, E., Kurmangaliyev, Y. Z., Cousins, H. C., Patel, M., Hernandez, J., Zhang, K. X., Samuel, M. A., Morey, M., Sanes, J. R., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.004 · Cited by 90
Zhang, H., Zhang, Z., Wang, Y., Wang, M., Wang, X., Zhang, X., Ji, S., Du, C., Chen, H., & Wang, X. (2019) · Journal of Virology · doi:10.1128/jvi.00174-19 · Cited by 90
Cpf1 enables fast and efficient genome editing in Aspergilli
Vanegas, K. G., Jarczynska, Z. D., Strucko, T., & Mortensen, U. H. (2019) · Fungal Biology and Biotechnology · doi:10.1186/s40694-019-0069-6 · Cited by 90
Papes, F., Camargo, A. P., de Souza, J. S., Carvalho, V. M. D. A., Szeto, R. A., LaMontagne, E., Júnior, J. R. T., Avansini, S. H., Sánchez-Sánchez, S. M., Nakahara, T. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29942-w · Cited by 95
Recent Developments in Systems Biology and Metabolic Engineering of Plant–Microbe Interactions
Kumar, V., Baweja, M., Singh, P. K., & Shukla, P. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01421 · Cited by 89
Rescue of high-specificity Cas9 variants using sgRNAs with matched 5’ nucleotides
Kim, S., Bae, T., Hwang, J., & Kim, J. (2017) · Genome biology · doi:10.1186/s13059-017-1355-3 · Cited by 86
Generalizable sgRNA design for improved CRISPR/Cas9 editing efficiency
Hiranniramol, K., Chen, Y., Liu, W., & Wang, X. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa041 · Cited by 93
Mekler, V. M., Станиславович, М. Л., Semenova, E., Kuznedelov, K. D., & Severinov, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw138 · Cited by 93
Suppression of pervasive noncoding transcription in embryonic stem cells by esBAFPreprint
Hainer, S. J., Gu, W., Carone, B. R., Landry, B. D., Rando, O. J., Mello, C. C., & Fazzio, T. G. (2015) · Genes & Development · doi:10.1101/gad.253534.114 · Cited by 84
Turan, S., Farruggio, A. P., Srifa, W., Day, J., & Calos, M. P. (2016) · Molecular Therapy · doi:10.1038/mt.2016.40 · Cited by 88
Yamamoto, Y., Makiyama, T., Harita, T., Sasaki, K., Wuriyanghai, Y., Hayano, M., Nishiuchi, S., Kohjitani, H., Hirose, S., Chen, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx073 · Cited by 91
Scalable Design of Paired CRISPR Guide RNAs for Genomic Deletion
Pulido-Quetglas, C., Aparicio-Prat, E., Arnan, C., Polidori, T., Hermoso, A., Palumbo, E., Ponomarenko, J. V., Guigó, R., & Johnson, R. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005341 · Cited by 90
Efficient high-precision homology-directed repair-dependent genome editing by HDRobust
Riesenberg, S., Kanis, P., Macak, D., Wollny, D., Düsterhöft, D., Kowalewski, J., Helmbrecht, N., Maričić, T., & Pääbo, S. (2023) · Nature Methods · doi:10.1038/s41592-023-01949-1 · Cited by 87
Efficient genome engineering approaches for the short-lived African turquoise killifish
Harel, I., Valenzano, D. R., & Brunet, A. (2016) · Nature Protocols · doi:10.1038/nprot.2016.103 · Cited by 89
CRISPR/Cas9: Transcending the Reality of Genome Editing
Chira, S., Gulei, D., Hajitou, A., Zimța, A., Cordelier, P., & Berindan‐Neagoe, I. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.04.001 · Cited by 89
Nishijima, Y., Hagiya, Y., Kubo, T., Takei, R., Katoh, Y., & Nakayama, K. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-01-0017 · Cited by 86
Beyond Native Cas9: Manipulating Genomic Information and Function
Mitsunobu, H., Teramoto, J., Nishida, K., & Kondo, A. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.004 · Cited by 87
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Chen, Y., & Zhang, Y. (2018) · Advanced Science · doi:10.1002/advs.201700964 · Cited by 91
Duchêne, B. L., Cherif, K., Iyombe-Engembe, J.-P., Guyon, A., Rousseau, J., Ouellet, D. L., Barbeau, X., Lagüe, P., & Tremblay, J. P. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.08.010 · Cited by 89
Is it possible to reconstruct an accurate cell lineage using CRISPR recorders?
Salvador‐Martínez, I., Grillo, M., Averof, M., & Telford, M. J. (2019) · eLife · doi:10.7554/elife.40292 · Cited by 83
CRISPR-mediated accelerated domestication of African rice landraces
Lacchini, E., Kiegle, E., Castellani, M., Adam, H., Jouannic, S., Gregis, V., & Kater, M. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229782 · Cited by 86
“Together with recent advances in CRISPR-Cas9 genome editing technology [13] [14], this knowledge creates unprecedented opportunities for crop improvement.”
BackgroundReilly, S. K., Gosai, S. J., Gutierrez, A., Mackay-Smith, A., Ulirsch, J. C., Kanai, M., Mouri, K., Berenzy, D., Kales, S., Butler, G. M., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00900-4 · Cited by 86
Optimized nickase- and nuclease-based prime editing in human and mouse cells
Adikusuma, F., Lushington, C., Arudkumar, J., Godahewa, G. I., Chey, Y. C. J., Gierus, L., Piltz, S., Geiger, A., Jain, Y., Reti, D., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab792 · Cited by 90
“We suspect that the low efficiency of the +2 A to C edit using PE-nuclease was due to re-cutting, as the 1-nt substitution was located in the gRNA targeting sequence (8,9).”
Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer
Álvarez‐Fernández, M., Sanz‐Flores, M., Sanz‐Castillo, B., Salazar‐Roa, M., Partida, D., Zapatero‐Solana, E., Ali, H. R., Manchado, E., Lowe, S. W., VanArsdale, T. L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0024-0 · Cited by 82
Chemically Modified Cpf1-CRISPR RNAs Mediate Efficient Genome Editing in Mammalian Cells
McMahon, M. A., Prakash, T. P., Cleveland, D. W., Bennett, C. F., & Rahdar, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.031 · Cited by 87
Development and Application of Base Editors
Yang, B., Yang, L. C., & Chen, J. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0001 · Cited by 87
Genetically modified pigs are protected from classical swine fever virus
Xie, Z., Pang, D., Yuan, H., Jiao, H., Lu, C., Wang, K., Yang, Q., Li, M., Chen, X., Yu, T., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007193 · Cited by 86
Shi, H., Tao, T., Abraham, B. J., Durbin, A. D., Zimmerman, M. W., Kadoch, C., & Look, A. T. (2020) · Science Advances · doi:10.1126/sciadv.aaz3440 · Cited by 87
Loupe, J. M., Pinto, R. M., Kim, K., Gillis, T., Mysore, J. S., Andrew, M. A., Kovalenko, M. V., Murtha, R., Seong, I., Gusella, J. F., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa196 · Cited by 85
“edu/) (43), cloned into the pSpCas9(BB)-2A-Puro (PX459) V2.”
Minimal genome-wide human CRISPR-Cas9 library
Gonçalves, E., Thomas, M., Behan, F. M., Picco, G., Pacini, C., Allen, F. R., Vinceti, A., Sharma, M., Jackson, D. A., Price, S., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02268-4 · Cited by 87
One-step generation of myostatin gene knockout sheep via the CRISPR/Cas9 system
(2014) · Frontiers of Agricultural Science and Engineering · doi:10.15302/j-fase-2014007 · Cited by 86
Pathogenesis of ELANE-mutant severe neutropenia revealed by induced pluripotent stem cells
Nayak, R. C., Trump, L. R., Aronow, B. J., Myers, K. C., Mehta, P. A., Kalfa, T. A., Wellendorf, A. M., Valencia, C. A., Paddison, P. J., Horwitz, M. S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80924 · Cited by 88
Lin, C., Li, H., Hao, M., Xiong, D., Luo, Y., Huang, C., Yuan, Q., Zhang, J., & Xia, N. (2016) · Scientific Reports · doi:10.1038/srep34531 · Cited by 85
Guide RNA engineering for versatile Cas9 functionality
Nowak, C. M., Lawson, S., Zerez, M., & Bleris, L. G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw908 · Cited by 83
Infection Exposure Promotes ETV6-RUNX1 Precursor B-cell Leukemia via Impaired H3K4 Demethylases
Rodríguez-Hernández, G., Hauer, J., Martín‐Lorenzo, A., Schäfer, D., Bartenhagen, C., García‐Ramírez, I., Auer, F., González‐Herrero, I., Ruiz-Roca, L., Gombert, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0701 · Cited by 86
A technological and regulatory outlook on CRISPR crop editing
Globus, R., & Qimron, U. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26303 · Cited by 89
Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption
Gopalappa, R., Suresh, B., Ramakrishna, S., & Kim, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky222 · Cited by 86
Genomes in Focus: Development and Applications of CRISPR‐Cas9 Imaging Technologies
Knight, S. C., Tjian, R., & Doudna, J. A. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201709201 · Cited by 86
Hallmarks of cancer: The CRISPR generation
Moses, C., García‐Bloj, B., Harvey, A. R., & Blancafort, P. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.01.002 · Cited by 90
Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides
Ding, X. L., Seebeck, T., Feng, Y., Jiang, Y., Davis, G. D., & Chen, F. (2019) · The CRISPR Journal · doi:10.1089/crispr.2018.0036 · Cited by 87
In vivo blunt-end cloning through CRISPR/Cas9-facilitated non-homologous end-joining
Geisinger, J. M., Turan, S., Hernandez, S., Spector, L. P., & Calos, M. P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1542 · Cited by 86
Deep learning improves the ability of sgRNA off-target propensity prediction
Liu, Q., Cheng, X., Liu, G., Li, B., & Liu, X. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-3395-z · Cited by 88
Vilalta, A., Zhou, Y., Sevalle, J., Griffin, J. K., Satoh, K., Allendorf, D. H., De, S., Puigdellívol, M., Bruzas, A., Burguillos, M. A., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100631 · Cited by 77
“Guide RNAs for each of the CRISPR genomic edits were assessed by two different programs for off-target sites (38, 39).”
MethodZhu, Y. (2022) · BioMed Research International · doi:10.1155/2022/9978571 · Cited by 103
“The o ff -target e ff ect is relatively low when the ratio of gRNA: Cas9 is between 2:1 – 3:1 [104].”
Fetal haemoglobin induction in sickle cell disease
Paikari, A., & Sheehan, V. (2017) · British Journal of Haematology · doi:10.1111/bjh.15021 · Cited by 90
Mason, D. M., Weber, C. R., Parola, C., Meng, S. M., Greiff, V., Kelton, W., & Reddy, S. T. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky550 · Cited by 87
Mukherjee, J., Johannessen, T.-C. A., Ohba, S., Chow, T. T., Jones, L. E., Pandita, A., & Pieper, R. O. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2269 · Cited by 87
Integrated design, execution, and analysis of arrayed and pooled CRISPR genome-editing experiments
Canver, M. C., Haeussler, M., Bauer, D. E., Orkin, S. H., Sanjana, N. E., Shalem, O., Yuan, G., Zhang, F., Concordet, J., & Pinello, L. (2018) · Nature Protocols · doi:10.1038/nprot.2018.005 · Cited by 91
Self-citationFlexible guide-RNA design for CRISPR applications using Protospacer Workbench
MacPherson, C. R., & Scherf, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3291 · Cited by 84
CRISPR/Cas9 for plant genome editing: accomplishments, problems and prospects
Paul, J. W., & Qi, Y. (2016) · Plant Cell Reports · doi:10.1007/s00299-016-1985-z · Cited by 90
Genome editing in crop improvement: Present scenario and future prospects
Miglani, G. S. (2017) · Journal of Crop Improvement · doi:10.1080/15427528.2017.1333192 · Cited by 86
Control of actin polymerization via the coincidence of phosphoinositides and high membrane curvature
Daste, F., Walrant, A., Holst, M. R., Gadsby, J. R., Mason, J., Lee, J., Brook, D., Mettlen, M., Larsson, E., Lee, S. F., et al. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201704061 · Cited by 83
Yuen, G., Khan, F. J., Gao, S., Stommel, J. M., Batchelor, E., Wu, X., & Luo, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx843 · Cited by 89
Self-citationMicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs
Kurata, J. S., & Lin, R.-J. (2018) · RNA · doi:10.1261/rna.066282.118 · Cited by 82
Sharma, A. K., Nymark, M., Sparstad, T., Bones, A. M., & Winge, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32342-0 · Cited by 88
Moutal, A., Yang, X.-F., Li, W., Gilbraith, K. B., Luo, S., Cai, S., François‐Moutal, L., Chew, L. A., Yeon, S. K., Bellampalli, S. S., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000001002 · Cited by 83
Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders
Christie, K. A., Courtney, D., DeDionisio, L., Chao-Shern, C., Majumdar, S. D., Mairs, L., Nesbit, M. A., & Moore, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-16279-4 · Cited by 83
Wang, Y., Long, H., Yu, J., Dong, L., Wassef, M. A., Zhuo, B., Li, X., Zhao, J., Wang, M., Liu, C., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0568-6 · Cited by 81
Challenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants
Vu, T. V., Sung, Y. W., Kim, J., Tran, M. T., Tran, M. T., & Kim, J. (2019) · Rice · doi:10.1186/s12284-019-0355-1 · Cited by 83
Mianné, J., Codner, G. F., Caulder, A., Fell, R., Hutchison, M., King, R., Stewart, M. E., Wells, S. E., & Teboul, L. (2017) · Methods · doi:10.1016/j.ymeth.2017.03.016 · Cited by 83
Fu, Y., Yang, Y., Zhang, H., Farley, G., Wang, J., Quarles, K. A., Weng, Z., & Zamore, P. D. (2018) · eLife · doi:10.7554/elife.31628 · Cited by 87
Liu, Q., He, D., & Xie, L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007480 · Cited by 86
CRISPR Tools To Control Gene Expression in Bacteria
Vigouroux, A., & Bikard, D. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00077-19 · Cited by 84
Control of Plant Viruses by CRISPR/Cas System-Mediated Adaptive Immunity
Cao, Y., Zhou, H., Zhou, X., & Li, F. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.593700 · Cited by 88
The tracrRNA in CRISPR Biology and Technologies
Liao, C., & Beisel, C. L. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-022559 · Cited by 91
Lopes, R., & Prasad, M. K. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1339189 · Cited by 82
“This concern stems from the well-documented evidence that CRISPR-Cas is prone to cause unwanted DNA alterations (Hsu et al., 2013; Mali et al., 2013).”
BackgroundPlant–pathogen interactions: toward development of next-generation disease-resistant plants
Nejat, N., Rookes, J. E., Mantri, N. L., & Cahill, D. M. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2015.1134437 · Cited by 86
Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease
Doetschman, T., & Georgieva, T. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309727 · Cited by 91
Molecular Therapies for Inherited Retinal Diseases—Current Standing, Opportunities and Challenges
Vázquez-Domínguez, I., Garanto, A., & Collin, R. W. J. (2019) · Genes · doi:10.3390/genes10090654 · Cited by 80
Zhong, H., Chen, Y., Li, Y., Chen, R., & Mardon, G. (2015) · Scientific Reports · doi:10.1038/srep08366 · Cited by 81
Self-citationExciting Prospects for Precise Engineering of Caenorhabditis elegans Genomes with CRISPR/Cas9
Frøkjær‐Jensen, C. (2013) · Genetics · doi:10.1534/genetics.113.156521 · Cited by 79
Enhanced NK-92 Cytotoxicity by CRISPR Genome Engineering Using Cas9 Ribonucleoproteins
Huang, R., Shih, H.-A., Lai, M., Chang, Y.-J., & Lin, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01008 · Cited by 81
“com) based on the published algorism (25).”
Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
Mohamed, H., Gurrola, T., Berman, R., Collins, M., Sariyer, I. K., Nonnemacher, M. R., & Wigdahl, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.816515 · Cited by 81
CRISPR/Cas9 Nuclease Cleavage Combined with Gibson Assembly for Seamless Cloning
Wang, J., Wang, A., Li, K., Wang, B., Jin, S., Reiser, M. A., & Lockey, R. F. (2015) · BioTechniques · doi:10.2144/000114261 · Cited by 80
Multiplex Engineering of Industrial Yeast Genomes Using CRISPRm
Ryan, O. W., & Cate, J. H. D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00023-4 · Cited by 84
Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes
Richardson, C. D., Ray, G. J., Bray, N., & Corn, J. E. (2016) · Nature Communications · doi:10.1038/ncomms12463 · Cited by 85
Imaging Specific Genomic DNA in Living Cells
Chen, B., Guan, J., & Huang, B. (2016) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-062215-010830 · Cited by 77
Raveux, A., Vandormael‐Pournin, S., & Cohen‐Tannoudji, M. (2017) · Scientific Reports · doi:10.1038/srep42661 · Cited by 81
Chen, J., Lai, Y., Wang, L., Zhai, S., Zou, G., Zhou, Z., Cui, C., & Wang, S. (2017) · Scientific Reports · doi:10.1038/srep45763 · Cited by 83
Umemura, Y. M., Koike, N., Ohashi, M., Tsuchiya, Y., Meng, Q., Minami, Y., Hara, M., Hisatomi, M., & Yagita, K. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703170114 · Cited by 80
CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs
Coelho, M. A., Braekeleer, E. D., Firth, M. A., Biśta, M., Łukasiak, S., Cuomo, M. E., & Taylor, B. (2020) · Nature Communications · doi:10.1038/s41467-020-17952-5 · Cited by 84
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Yuan, Q., & Gao, X. (2022) · Nature Communications · doi:10.1038/s41467-022-30514-1 · Cited by 85
Genome-wide CRISPR off-target prediction and optimization using RNA-DNA interaction fingerprints
Chen, Q., Chuai, G., Zhang, H., Tang, J., Duan, L., Guan, H., Li, W., Li, W., Wen, J., Zuo, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42695-4 · Cited by 89
“For each position, we collected the top features (Supplementary Data 2) and their SHAP score values (Supplementary Data 2).”
BackgroundInfluentialIn Vivo Ovarian Cancer Gene Therapy Using CRISPR-Cas9
He, Z., Zhang, Y., Yang, Y., Ma, C., Wang, P., Du, W. T., Li, L., Xiang, R., Song, X., Zhao, X., et al. (2018) · Human Gene Therapy · doi:10.1089/hum.2017.209 · Cited by 81
Engineering Clostridium organisms as microbial cell-factories: challenges & opportunities
Charubin, K., Bennett, R. K., Fast, A. G., & Papoutsakis, E. T. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.07.012 · Cited by 82
Ji, H., Jiang, Z., Lu, P., Ma, L., Li, C., Pan, H., Fu, Z., Qu, X., Wang, P., Deng, J., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.7 · Cited by 80
CRISPR system in filamentous fungi: Current achievements and future directions
Deng, H., Gao, R., Liao, X., & Cai, Y. (2017) · Gene · doi:10.1016/j.gene.2017.06.019 · Cited by 81
Rahman, M. K., & Rahman, M. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181943 · Cited by 79
Synthetic AAV/CRISPR vectors for blocking HIV‐1 expression in persistently infected astrocytes
Kunze, C., Börner, K., Kienle, E., Orschmann, T., Rusha, E., Schneider, M., Radivojkov‐Blagojevic, M., Drukker, M., Desbordes, S. C., Grimm, D., et al. (2017) · Glia · doi:10.1002/glia.23254 · Cited by 82
Rico, E., Jeacock, L., Kovářová, J., & Horn, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-26303-w · Cited by 83
Comparative analysis of single-stranded DNA donors to generate conditional null mouse alleles
Lanza, D. G., Gaspero, A., Lorenzo, I., Liao, L., Zheng, P., Wang, Y., Deng, Y., Cheng, C., Zhang, C., Rasband, M. N., et al. (2018) · BMC Biology · doi:10.1186/s12915-018-0529-0 · Cited by 78
Krchňáková, Z., Thakur, P. K., Krausová, M., Bieberstein, N. I., Haberman, N., Müller-McNicoll, M., & Staněk, D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1147 · Cited by 78
Application of the CRISPR/Cas system for genome editing in microalgae
Zhang, Y., Jiang, J., Shi, T., Sun, X., Zhao, Q., Huang, H., & Ren, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09726-x · Cited by 82
Sanjurjo-Soriano, C., Erkilic, N., Baux, D., Mamaeva, D. V., Hamel, C., Meunier, I., Roux, A., & Kalatzis, V. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.016 · Cited by 82
Zhang, G., Dai, Z., & Dai, X. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.01.013 · Cited by 80
“Note that, CRISPR can tolerate mismatches in sgRNA-Fig DNA at various positions in a sequence-dependent manner, leading to off-target mutations [54,55].”
BackgroundMouse γ-Synuclein Promoter-Mediated Gene Expression and Editing in Mammalian Retinal Ganglion Cells
Qizhao, W., Zhuang, P., Huang, H., Li, L., Liu, L., Webber, H. C., Dalal, R., Siew, L., Fligor, C. M., Chang, K., et al. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0102-20.2020 · Cited by 82
““Cas-OFFinder” found no potential off-targets based on “All” (Hsu et al., 2013) and “Seed” (Cong et al.”
BackgroundInfluentialCRISPR Interference To Inducibly Repress Gene Expression in Chlamydia trachomatis
Ouellette, S. P., Blay, E. A., Hatch, N. D., & Fisher, L. A. (2021) · Infection and Immunity · doi:10.1128/iai.00108-21 · Cited by 79
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D. Z., Thomas, C. J., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.005 · Cited by 80
“The design principle of sgRNA was based on previous reports: (1) sgRNAs with the predicted low off-target effect (Hsu et al., 2013) and (2) sgRNAs targeting the functional protein domain region (Shi et al.”
MethodNewer Gene Editing Technologies toward HIV Gene Therapy
Manjunath, N., Yi, G., Dang, Y., & Shankar, P. (2013) · Viruses · doi:10.3390/v5112748 · Cited by 77
Metadata
- Authors
- Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., Cradick, T. J., Marraffini, L. A., Bao, G., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Georgia Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Rockefeller University (US)
- Corresponding author
- Zhang, Feng
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2013-07-21
- Volume
- 31
- Issue
- 9
- Pages
- 827-832
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC3969858
- OpenAlex
- W2036176224
- Cited by
- 4,741
- References
- 29
- Citations by year
- 2026: 242 · 2025: 300 · 2024: 304 · 2023: 331 · 2022: 372 · 2021: 424 · 2020: 416 · 2019: 422 · 2018: 463 · 2017: 438 · 2016: 402 · 2015: 297 · 2014: 269 · 2013: 53
- FWCI
- 152.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion)
- PMC
- Funders
- National Science Foundation
- Howard Hughes Medical Institute
- Damon Runyon Cancer Research Foundation
- McKnight Foundation
- Life Sciences Research Foundation
- National Institutes of Health (R01‐grant, GM34277)
- Harvard Stem Cell Institute
- National Institute of Mental Health (DP1MH100706)
- National Eye Institute (PN2EY018244)
- National Cancer Institute (R01CA133404)
- National Institute of General Medical Sciences (R01GM034277, R01 GM34277, T32GM007753)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK097768)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- SpCas9, single guide RNA, genome editing, off-target effects, mismatch tolerance, DNA methylation, indel mutations, guide RNA design, target site selection, HEK293T cells, web-based design tool
- MeSH terms
- Bacterial Proteins, Base Sequence, Deoxyribonucleases, DNA, Genetic Engineering, Molecular Sequence Data, Streptococcus pyogenes, Transcription Factors, Base Pair Mismatch, RNA, Small Untranslated
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
